E. Blair Solow

The University of Texas Southwestern Medical Center

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis”.

A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis

Arthritis & Rheumatology(2025)10.1002/art.43366

N/A

0DataRank · unranked

16 citations

Christopher C. Striebich, Marie L. Feser, James R. O’Dell, Judith A. James, Jeffrey A. Sparks +29 more

Genetic or therapeutic disruption of the Reelin/Apoer2 signaling pathway improves inflammatory arthritis outcomes

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2418642122

N/A

0DataRank · unranked

3 citations

Catherine R. Wasser, E. Blair Solow, Sharon Wu, Bret M. Evers, David S. Karp +3 more